Cutaneous manifestations and histological features of microscopic polyangiitis

European Journal of Dermatology

Volumn 19, Issue 1, 2009, Pages 57-60

  Nagai, Yayoi ^a   Hasegawa, Michiko ^a   Igarashi, Naoya ^a   Tanaka, Setsuko ^a   Yamanaka, Masayoshi ^a   Ishikawa, Osamu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Livedo racemosa; Microscopic polyangiitis; MPO ANCA; Pupura; Systemic sclerosis

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; C REACTIVE PROTEIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HEPARIN; METHYLPREDNISOLONE; MYELOPEROXIDASE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; FATALITY; FEMALE; GLOMERULONEPHRITIS; HEADACHE; HEMATURIA; HUMAN; IMMUNOFLUORESCENCE TEST; KIDNEY BIOPSY; LEG EDEMA; LYMPHOCYTIC INFILTRATION; MALE; MICROSCOPIC POLYANGIITIS; MONONEUROPATHY; NECROTIZING ARTERITIS; NEUTROPHIL CHEMOTAXIS; PROTEINURIA; PURPURA; RAYNAUD PHENOMENON; RESPIRATORY FAILURE; SKIN BIOPSY; SYSTEMIC SCLEROSIS; UREA NITROGEN BLOOD LEVEL;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SKIN DISEASES, VASCULAR; VASCULITIS;

EID: 60549102448     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: 10.1684/ejd.2008.0566     Document Type: Article

References (25)

1. Jannette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
2. Saito R. Microscopic polyangiitis. Rinsho Derma 2004; 46: 1436-41.
3. Akimoto S, Ishikawa O, Tsukada Y, et al. Microscopic polyangiitis mimicking Henoch-Schönlein purpura followed by severe renal involvement: a diagnostic role for antineutrophil cytoplasmic outoantibody. Br J Dermatol 1997; 136: 298-9.
4. Agard C, Mouthon L, Mohr A, et al. Microscopic polyangiitis and polyarteritis noclosa: how and when do they start? Arthritis Rheum 2003; 49: 709-15.
5. Savage CO, Winearls CG, Evans DJ, et al. Microscopic polyangiitis: presentation, pathology and prognosis. Q J Med 1985; 65: 467-83.
6. Gaskin G, Pusey C. Immunology of systemic vasculitis. Ann Med Intern 1992; 143: 57-62.
7. Andrassy K, Koderisch J, Rufer M, et al. Detection and clinical implication of anti neutrophil cytoplasm antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis. Clin nephrol 1989; 32: 159-67.
8. Cupps TR, Fauci AS. The vasculiticles. Major Probl Intern Med 198 1; 21: 1-211.
9. Kawakami T, Kawanabe T, Saito C, et al. Clinical and histopathologic features of 8 patients. with microscopic. polyangiitis including two with a slowl progressive clinical course. J Am Acad Dermatol 2007; 57: 840-4
10. Seishima M, Oyama Z, Oda M. Skin eruption associated with microscopic polyangiitis. Eur J Dermatol 2004; 14: 255-8.
11. Chen KR, Carison JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008; 9: 71-92.
12. Sunderkötter C, Sindrilaru A. Clinical classification of vasculitis. Eur J Dermatol 12006; 16: 113-24.
13. Nakabayashi K. Slowly progressive, not rapidly progressive, MPO-ANCA sitive glomerulonephritis and its characteristics. Intern Med 2002; 41: 418-9.
14. Franssen CF, Stegemen CA, Oost-Kort WW, et al. Determinants of renal outcome in antimyeloperoxidase-associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 1998; 9: 1915-23.
15. Aoyama T, Shimizu T, Matsuo T, et al. MPO-ANCA-positive slowly rogressive glomerulonephritis with focal tuft necrosis and crescents. Intern Med 2002; 41: 458-62.
16. Maejima H, Eto H. Microscopic polyangiitis. Pract Dermatol 2006; 24: 1223-6.
17. Asano S, Ishibashi M, Higaki Y, et al. Two cases of microscopic polyangiitis. Rinsho Derma 2004; 58: 1150-3.
18. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmic outoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 1994; 21: 864-70.
19. Akimoto S, Ishikawa O, Tamura T, et al. Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 1996; 134: 407-10.
20. Locke IC, Worrall JG, Leaker B, et al. Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol 1997; 24: 86-9.
21. Merkel PA, Polisson RP, Chang Y, et al. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 1997; 126: 866-73.
22. Ruffatti A, Sinco RA, Radice A, et al. Autoantibodies to proteinase 3 and myeloperoxidase in systemic sclerosis. J Rheumatol 2002; 29: 918-23.
23. Hoffman GS, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998; 41: 1521-37.
24. Hillis GS, Kohn H, Simpson JG, et al. Sclerodermal D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies. Am J Kid Dis 1997; 30: 279-81.
25. Ishibuchi H, Nagai Y, Endo Y, et al. Two cases of systemic sclerosis with multiple skin ulcers and gangrene. Skin Research 2006; 5: 148-52.